Details

Autor(en) / Beteiligte

• Alfieri, Valentina
• Myasoedova, Veronika A.
• Vinci, Maria Cristina
• Rondinelli, Maurizio
• Songia, Paola
• Massaiu, Ilaria
• Cosentino, Nicola
• Moschetta, Donato
• Valerio, Vincenza
• Ciccarelli, Michele
• Marenzi, Giancarlo
• Genovese, Stefano
• Poggio, Paolo

Titel

The Role of Glycemic Variability in Cardiovascular Disorders

Ist Teil von

• International journal of molecular sciences, 2021-08, Vol.22 (16), p.8393

Ort / Verlag

Basel: MDPI AG

Erscheinungsjahr

2021

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Diabetes mellitus (DM) is one of the most common and costly disorders that affect humans around the world. Recently, clinicians and scientists have focused their studies on the effects of glycemic variability (GV), which is especially associated with cardiovascular diseases. In healthy subjects, glycemia is a very stable parameter, while in poorly controlled DM patients, it oscillates greatly throughout the day and between days. Clinically, GV could be measured by different parameters, but there are no guidelines on standardized assessment. Nonetheless, DM patients with high GV experience worse cardiovascular disease outcomes. In vitro and in vivo studies showed that high GV causes several detrimental effects, such as increased oxidative stress, inflammation, and apoptosis linked to endothelial dysfunction. However, the evidence that treating GV is beneficial is still scanty. Clinical trials aiming to improve the diagnostic and prognostic accuracy of GV measurements correlated with cardiovascular outcomes are needed. The present review aims to evaluate the clinical link between high GV and cardiovascular diseases, taking into account the underlined biological mechanisms. A clear view of this challenge may be useful to standardize the clinical evaluation and to better identify treatments and strategies to counteract this DM aspect.